Actively Recruiting
LUNG INFECTION in ICU (LUNG-I3)
Led by BioMérieux · Updated on 2025-02-12
68
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
objective of LUNG-I3 study is to assess the quantitative and functional differences in cells between blood and bronchoalveolar lavage (BAL) fluid after an infection, with a special focus on alveolar macrophages and neutrophils
CONDITIONS
Official Title
LUNG INFECTION in ICU (LUNG-I3)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or greater
- Severe ICU patients hospitalized for septic shock caused by pneumonia or another source
- Severe trauma patients with Injury Severity Score of 25 or higher
- Burn patients with total body surface area over 20%
- NAD greater than 0.1 �b5g/kg/min
- At least 2 SOFA criteria with score of 2 or more points
You will not qualify if you...
- Aspiration pneumonia
- Unable to provide valid written consent or have a legally authorized representative provide consent
- Chronic obstructive pulmonary disease (COPD)
- Smoke inhalation in burn patients
- Participation in another intervention study
- Pregnant or breastfeeding women
- Immunocompromised patients, including those with recent chemotherapy, progressive metastatic disease, hematologic malignancies, solid organ transplantation, HIV infection, or on long-term corticosteroids or other immunosuppressive drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hopital Edouard Herriot
Lyon, France, 69003
Actively Recruiting
Research Team
J
Jean-François LLITJOS
CONTACT
M
Marie-Angelique CAZALIS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here